| NDDS products developed by the company |
| Products |
Therapeutic Segment |
| Clarie DT (Dispersible Tablet) |
Macrolide |
| Clarie OD |
Macrolide |
| Clarie SR (Sustained Release) |
Macrolide |
| Excef DT (Dispersible Tablet) |
Antibiotic |
| Suprox SR (Sustained Release) |
Vasodilator |
| Fexidine Kid Tab (Dispersible Tablet) |
Anti histamine |
| Netazox DT (Dispersible Tablet) |
Anti diarrhea |
| Agile SR Tab (Sustained Release) |
Anti inflammatory |
| Askil tablet (mouth dissolving) |
Anti inflammatory |
| Roxy Kid Tab |
Macrolide |
| Montelukast chewable tablet |
Anti asthmatic |
| Metformin SR (Sustained Release) |
Anti diabetic |
| Acamprostate enteric coated |
Anti alcoholic |
| |
| Global Launch Status (with regard to the originator) |
| Products |
Status |
| Clarithromycin dispersible tablets |
First |
| Fexofenadine dispersible tablets/ mouth dissolving NDDS |
First |
| Roxithromycin taste masked granules |
First |
| Roxithromycin dispersible tablets |
First |
| Clarithromycin taste masked granules |
Second |
| Clarithromycin sustained release tablets |
Second |
| Netazoxanide dispersible tablets/ dry syrup |
Second |
| |
